News & Articles

Dr. Richard Knight, medical director of transplant diagnostics at Thermo Fisher Scientific explores personalized, non‑invasive approaches designed to improve transplant success

Guest editorial by Kerstin Wagner, Co-CEO & COO, United Robotics Group

In this guest editorial discover what remains in our arsenal to combat antibiotic resistance, and how HORIBA Medical is advancing responsible prescribing to protect patient outcomes

Communication, engagement and promotion in a modern world — Terry Taylor, past president of The New Zealand Institute of Medical Laboratory Science (Inc.) shares his views in this guest editorial

Guest editorial by Susan Dawson, retired laboratory leader and founder of Accomplish More Consulting Services (AMCS)

Pioneering the future of laboratory medicine with AI-driven diagnostics

In this guest editorial, Dr. Katherine Bridge, University of York, explains how aptamers could unlock new opportunities for more targeted and effective cancer treatments

Championing biomedical science, combating antimicrobial resistance, and inspiring future generations in Africa

Quanterix Director of Medical Affairs discusses the advances revolutionizing Alzheimer’s diagnosis and care

Learn about the future of newborn screening in this guest editorial from Clinical and Laboratory Standards Institute

Letter from the managing editor

In sepsis, the delay of even one hour in diagnosis can mean the difference between life and death. What if a standard blood test powered by AI, could flag the risk before symptoms even appear?

Radiometer’s blood gas and immunoassay POC analysers deliver critical parameters enabling critical care teams to make quick decisions fast

Guest editorial by Dale Powner, Country Manager for the UK, Ireland and Nordics at Binding Site, part of Thermo Fisher Scientific

One lab shares its experience switching to Streck’s quality control solution for molecular diagnostics testing

Discover how advances in dried blood spot testing are advancing biomarker analysis and sample collection

New blood test unveiled developed using artificial intelligence could lead to improved patient outcomes

Elecsys pTau181 is the first in vitro diagnostic regulation (IVDR)-certified test to rule out Alzheimer’s associated amyloid pathology

Designed for use in decentralized, CLIA-waived settings, the test has been analytically verified in a study to deliver results comparable to standard laboratory methods

Platform is built on biologically labelled, organ-specific multi-omics data carried by extracellular vesicles isolated from 2ml plasma samples

Over 200 exhibitors, AI-powered breakthroughs, and strategic forums set to transform regional healthcare

SelectScience clinical CPD webinars can be added to HCPC and IBMS portfolios as evidence of CPD

Due to its precise analytical performance, the HLC-723 GR01 enhances diagnostic confidence, supporting both high throughput and improved diabetes care